Yesterday
Ramsay says Labor’s premium hike will not cover soaring hospital costs
Still, shares in the country’s largest private hospital operator rose sharply after it appointed Goldman Sachs to assess the sale of its European business.
This Month
Health insurance premiums to rise 3.7pc in new cost-of-living hit
Health Minister Mark Butler has signed off on an above-inflation hike in private health insurance premiums, the biggest rise since 2018.
Telix Pharma CEO in $120m block trade; taps JPMorgan
Telix boss Christian Behrenbruch and the other seller had agreed to a 12-month escrow.
Big pharma sues GenesisCare over Labor-endorsed copycat cancer drug
Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund and regulate nuclear medicines escalates.
Why a Mediscare campaign won’t be so easy this time around
Labor’s Medicare package offers politically popular relief for GP visits but may not convince voters losing confidence in Australia’s public health system.
Genesis Capital gets back into general practice with Ochre Health
Genesis has partnered with doctor Hamish Meldrum who will keep a significant shareholding in the business.
Doctors say not all GP visits will be free under Labor plan
Medical professionals welcome the $8.5 billion Medicare overhaul but urge targeted funding to care for patients who need it most.
Star biotech Telix makes $1.2b revenue pledge
The Melbourne-based nuclear medicine company is expected to be a major player in the US radiopharmaceutical market.
Ramsay’s global CFO search for a hospital pass job
Does the healthcare outfit really think someone will move to Australia to manage the colossal mess that is our private hospital market?
Healthscope to close maternity wards in Darwin and Hobart
The Coalition has seized on the shutdowns to accuse Labor of failing to take action to stop the closure of critical health service
TGA approves weight-loss drug to treat heart disease
Regulators say the weight-loss drug Wegovy can now be used to treat more than 3 million overweight Australians with heart disease.
Catholic Health’s new plan to fix hospitals at ‘breaking point’
Private hospital groups have sent Labor a package of proposals they say can save the struggling sector.
David Di Pilla’s HMC Capital eyes Healthscope hospitals
The alternative asset manager and other operators are talking to Healthscope’s landlords about taking over Australia’s second-biggest hospital group.
Cochlear says US cost-of-living pressures hit services revenue
Cochlear expects full-year earnings to come in at the lower end of guidance, despite rising sales of its implants.
Chemist Warehouse scores $34b pay day in ASX debut
The founders were on hand as the retailer made its sharemarket debut on Thursday via Sigma, with plans to expand in Australia and globally.
Is Ramsay Health Care whipping itself into a frenzy?
The private hospital lobby is turning on itself and Labor is making mileage from it.
Billionaire family backs Vitura’s purchase of medicinal cannabis firm
The ASX-listed company will acquire Candor Medical, a telehealth consultations provider, with the backing of wealthy businessman Charlie Shahin.
Gap in insurer refunds ‘shows need for health fund reform’
Doctors want an independent private health system authority to oversee conflicts between insurers and hospital groups over funding.
Advent eyes quick radiology flip with PEP on the scene
PEP is understood to me in talks to buy Advent Partners’s Imaging Associates with Sayers Group on the scene to advise.
Ramsay warns of no profit growth as it slashes British assets
Ramsay Health Care’s new chief executive, Natalie Davis, says first-half earnings will be weaker this year because of offshore impairments.
CSL war games manufacturing network in a world heading for trade war
The ASX-listed giant says it can switch manufacturing sites if Donald Trump imposes tariffs on pharmaceuticals. It expects double-digit earnings growth.
Doctors pitch $3b plan to slash GP visit costs
GPs will on Tuesday present a funding package to Canberra they say will make doctor visits affordable for younger Australians and people with chronic illness.
Mayne Pharma expects earnings to triple, shares jump 24pc
Shares in volatile drugmaker Mayne Pharma jumped 24 per cent on Monday after the company said it expected stronger first-half earnings and revenues.
Medical costs up, bulk billing down across Australia: report
Access to GPs is shaping up as a contentious issue for the coming federal election.
Big pharma steps up push for taxpayer-funded weight-loss drugs
Novo Nordisk and Eli Lilly have used submissions to the federal government’s budget process to argue reducing obesity will be less costly than later treatment.